Literature DB >> 22915343

The ovarian response to standard gonadotrophin stimulation depends on FSHR, SHBG and CYP19 gene synergism.

Leandros A Lazaros1, Elissavet G Hatzi, Christina E Pamporaki, Prodromos I Sakaloglou, Nectaria V Xita, Sophia I Markoula, Theodoros I Stefos, Konstantinos A Zikopoulos, Ioannis A Georgiou.   

Abstract

PURPOSE: Follicle stimulating hormone, sex hormone-binding globulin and cytochrome P450 aromatase play crucial roles in the regulation of mammalian reproduction. The synergistic effect of FSHR 307(T/A)/FSHR 680(N/S), SHBG(TAAAA) ( n ) and CYP19(TTTA) ( n ) genotypes on ovarian response to standard gonadotrophin stimulation of women undergoing medically assisted reproduction (IVF/ICSI) was explored.
METHODS: The study population consisted of 300 women under IVF/ICSI treatment and 300 women with at least with at least one successful child birth as controls. The polymorphisms were genotyped while the follicular size, the follicle and oocyte numbers were recorded during oocyte retrieval.
RESULTS: The genotype analysis, excluding heterozygotes for each particular polymorphism, revealed eight combined homozygotic FSHR/SHBG/CYP19 genotypes. A gradual reduction in the number of follicles and oocytes from FSHR 307Thr/680Asn allele/long SHBG allele/long CYP19 allele homozygotes to FSHR 307Ala/680Ser allele/short SHBG allele/short CYP19 allele homozygotes was observed (20.36 ± 6.74 vs. 8.05 ± 2.47, p < 0.008 and 13 ± 4.63 vs. 6.1 ± 2.32, p < 0.02, respectively).
CONCLUSIONS: FSHR/SHBG/CYP19 combined genotypes are associated with ovarian response to standard gonadotrophin stimulation of women undergoing medically assisted reproduction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22915343      PMCID: PMC3510364          DOI: 10.1007/s10815-012-9849-0

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  40 in total

1.  Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype.

Authors:  M Perez Mayorga; J Gromoll; H M Behre; C Gassner; E Nieschlag; M Simoni
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

2.  The effect of a null mutation in the follicle-stimulating hormone receptor gene on mouse reproduction.

Authors:  M H Abel; A N Wootton; V Wilkins; I Huhtaniemi; P G Knight; H M Charlton
Journal:  Endocrinology       Date:  2000-05       Impact factor: 4.736

3.  Association of serum and follicular fluid SHBG levels and SHBG (TAAAA)n polymorphism with follicle size in women undergoing ovarian stimulation.

Authors:  Elissavet Hatzi; Ioanna Bouba; Anna Galidi; Leandros Lazaros; Nectaria Xita; Prodromos Sakaloglou; Georgios Kolios; Eleni Bairaktari; Apostolos Kaponis; Konstantinos Zikopoulos; Agathocles Tsatsoulis; Ioannis Georgiou
Journal:  Gynecol Endocrinol       Date:  2010-06-14       Impact factor: 2.260

4.  Aromatase (CYP19) gene variants influence ovarian response to standard gonadotrophin stimulation.

Authors:  Leandros A Lazaros; Elissavet G Hatzi; Nectaria V Xita; Georgios V Makrydimas; Apostolos I Kaponis; Atsushi Takenaka; Ioannis P Kosmas; Nikolaos V Sofikitis; Theodoros I Stefos; Konstantinos A Zikopoulos; Ioannis A Georgiou
Journal:  J Assist Reprod Genet       Date:  2011-11-17       Impact factor: 3.412

5.  CYP19 gene: a genetic modifier of polycystic ovary syndrome phenotype.

Authors:  Nectaria Xita; Leandros Lazaros; Ioannis Georgiou; Agathocles Tsatsoulis
Journal:  Fertil Steril       Date:  2009-03-26       Impact factor: 7.329

6.  The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype.

Authors:  Nectaria Xita; Ioannis Georgiou; Leandros Lazaros; Vasiliki Psofaki; George Kolios; Agathocles Tsatsoulis
Journal:  Eur J Endocrinol       Date:  2008-06       Impact factor: 6.664

7.  A distribution of two SNPs in exon 10 of the FSHR gene among the women with a diminished ovarian reserve in Ukraine.

Authors:  Ganna Livshyts; Svetlana Podlesnaja; Sergey Kravchenko; Iryna Sudoma; Ludmila Livshits
Journal:  J Assist Reprod Genet       Date:  2008-11-25       Impact factor: 3.412

Review 8.  Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance.

Authors:  David B Seifer; David T Maclaughlin
Journal:  Fertil Steril       Date:  2007-06-07       Impact factor: 7.329

9.  Aromatase gene (CYP19A1) variants, female infertility and ovarian stimulation outcome: a preliminary report.

Authors:  Signe Altmäe; Kadri Haller; Maire Peters; Merli Saare; Outi Hovatta; Anneli Stavreus-Evers; Agne Velthut; Helle Karro; Andres Metspalu; Andres Salumets
Journal:  Reprod Biomed Online       Date:  2009-05       Impact factor: 3.828

Review 10.  Polymorphism of the FSH receptor and ovarian response to FSH.

Authors:  A Wunsch; B Sonntag; M Simoni
Journal:  Ann Endocrinol (Paris)       Date:  2007-06-04       Impact factor: 2.478

View more
  5 in total

1.  An in silico model using prognostic genetic factors for ovarian response in controlled ovarian stimulation: A systematic review.

Authors:  B S Eisele; G C Villalba Silva; C Bessow; R Donato; V K Genro; J S Cunha-Filho
Journal:  J Assist Reprod Genet       Date:  2021-03-31       Impact factor: 3.357

2.  Effect of Genetic Variants of Gonadotropins and Their Receptors on Ovarian Stimulation Outcomes: A Delphi Consensus.

Authors:  Alessandro Conforti; Frank Tüttelmann; Carlo Alviggi; Hermann M Behre; Robert Fischer; Liang Hu; Nikolaos P Polyzos; Dana Chuderland; Gottumukkala Achyuta Rama Raju; Thomas D'Hooghe; Manuela Simoni; Sesh K Sunkara; Salvatore Longobardi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-01       Impact factor: 5.555

3.  Association of follicle stimulating hormone receptor promoter with ovarian response in IVF-ET patients.

Authors:  Wang Dan; Gao Jing; Xia Liangbin; Zhang Ting; Zeng Ying
Journal:  Iran J Reprod Med       Date:  2015-11

4.  Human Umbilical Cord Mesenchymal Stem Cells Therapy in Cyclophosphamide-Induced Premature Ovarian Failure Rat Model.

Authors:  Dan Song; Yun Zhong; Chunfeng Qian; Qinyan Zou; Jian Ou; Yichao Shi; Liang Gao; Gaigai Wang; Zhenxing Liu; Haibo Li; Hailei Ding; Huihua Wu; Fuxin Wang; Jing Wang; Hong Li
Journal:  Biomed Res Int       Date:  2016-03-07       Impact factor: 3.411

5.  Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarian function in rats with premature ovarian insufficiency (POI) at least partly through a paracrine mechanism.

Authors:  Li Ling; Xiushan Feng; Tianqin Wei; Yan Wang; Yaping Wang; Ziling Wang; Dongyuan Tang; Yanjing Luo; Zhengai Xiong
Journal:  Stem Cell Res Ther       Date:  2019-01-25       Impact factor: 6.832

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.